Brind.
  1. ARS Pharmaceuticals depended on Caremark for expanded insurance coverage as of August 1, 2026.

Analyst estimates for ARS were lowered due to coverage failures and missed formulary dates related to its dependence on Caremark.

1 report, 1 independent Updated Aug 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Analyst estimates for ARS were lowered due to coverage failures and missed formulary dates related to its dependence on Caremark.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped